UPDATE: Due to the high circulation of the SARS-CoV-2 Omicron variant, our antibody combination is not currently authorized for use in any U.S. Region. Please refer to the authorized Fact Sheet and FDA statement for additional details.
Learn More

Transparency & Policies Regeneron Policies, Positions And Procedures

Regeneron recognizes that accountability and transparency are essential for responsible growth and a key component of doing well by doing good. We are dedicated to communicating transparently and sharing our progress as we advance on our responsibility journey. This page is intended for U.S. residents only.

Access and Affordability

Compassionate Use Requests

U.S. Pricing Philosophy

Business Practices

Code of Business Conduct and Ethics

Data Privacy Philosophy

Distributor Code of Conduct

Policy on Environment, Health and Safety

Position Statement on Human Rights

Purchase Order Terms and Conditions

Representative Regeneron U.S. Product Related Patents

Vendor Code

Healthcare Interactions

California – Annual Declaration of Compliance

Code on Global Interactions with HCPs

Disclosures on Transfers of Value to Members of the Healthcare Community

Public Policy and Disclosures

Policy on Corporate Political Contributions

Strategy in Relation to Taxation

Research

Clinical Trial Disclosure and Data Transparency Policy

Financial Conflict of Interest Policy for Public Health Funded Research

Position Statement on Ethics in Clinical Studies

Position Statement on Stem Cell Research

Responsibility Reporting

2022 Responsibility Report

2021 Responsibility Report

2020 Responsibility Report

2019 Responsibility Report

2018 Responsibility Report

2017 Responsibility Report

2022 TCFD Report

2022 Consolidated EEO-1 Form

2022 Regeneron ESG Data Summary

2022 CDP Climate Change Disclosure

2022 CDP Water Security Disclosure

2022 Verification Statement

Back
to top